Background: Parents and physicians may have different understandings of a child's risk of future limitations due to cancer or cancer treatment. We evaluated alignment between parent-and physician-estimated risk of late effects.
INTRODUCTION
In the current treatment era, over 80% of children diagnosed with cancer will become long-term survivors. 1 This cure is not without cost, as cancer and its treatments can cause long-term health effects well beyond completion of therapy. More than 60% of childhood cancer survivors experience at least one chronic medical condition, or late effect, of treatment. 2 Furthermore, cancer and its treatment may impair longterm health status, with over 40% of long-term survivors experiencing adverse health in at least one domain of general health, mental health, functional impairment, or activity limitations. 3, 4 However, little is known about how to best communicate the risk of late effects or future Abbreviations: CI, confidence interval; OR, odds ratio; QOL, quality of life functional impairment to patients and families, nor about parental interest in receiving late effects information early in treatment.
Though the risk of late effects and functional impairment has been well described, research suggests that this risk is not optimally conveyed to parents. Compared with information about treatment, parents report receiving lower quality information about what their child's diagnosis means for the future. 5 Many parents of survivors feel suboptimally prepared for their child's life after cancer treatment, 6 and parents continue to report unmet information needs about late effects well into their children's survivorship. 7 Many have attempted to mitigate this information gap through provision of health information and targeted educational interventions in survivorship clinics. 8, 9 However, the first discussions of potential late effects of cancer and its treatment typically occur during initial conversations about therapy, as this information is a necessary component of informed consent and may impact treatment decision making. In this study, we sought to better understand the communication process about risks of potential long-term effects of cancer and cancer treatment by evaluating parents' perceptions of their child's risk of future limitations in the early treatment period, shortly after they engaged in discussions about diagnosis and treatment. We particularly examined whether parents of children whom physicians considered to be at the highest risk of future limitations recognized this risk, and whether parents' desires for information about late effects varied based on their child's risk.
METHODS
We surveyed parents of children with cancer and the children's pedi- Three hundred eighty-two of 565 eligible parents (68%) completed the survey within 12 weeks of their child's diagnosis. Participation rates did not significantly differ by diagnosis group, although parents of children with brain tumors were slightly less likely to participate as compared with parents of children with hematologic malignancies or extracranial solid tumors (P = 0.07). Paired physician surveys were obtained for 361 of the 382 parent surveys (95%). Ninety-four physicians participated; 34 (36%) had a single patient enrolled, 33 (35%) physicians had two to three patients enrolled, and 27 (29%) had four or more patients enrolled. Nine surveys were excluded due to incomplete items for the primary outcome of future limitations (six parents and three physicians). In total, this analysis included 352 parents of children with cancer and their children's physicians.
Both parent and physician survey instruments utilized items or modified items drawn from previously developed questionnaires, 5, 10, 11 with new questions developed based on literature review, parent and physician interviews, and general principles of survey design. The survey instrument underwent pilot testing with parents and physicians for face and content validity prior to implementation. Parent survey instruments were available in English and Spanish, and parent and physician surveys were offered in paper-and-pencil or electronic format as per participant preference.
Study outcomes
The primary study outcome was parent understanding of his/her child's risk of future limitations, which was defined as agreement between parent and physician estimations of risk. Parents and physicians were asked to report the likelihood that a child would experience future functional limitations due to cancer or cancer treatment in three domains using previously developed items. 6, 10 Parents and physicians were asked to predict the likelihood of a child experiencing functional limitations in "physical abilities (such as difficulty exercising)," "intelligence (such as difficulty with schoolwork)," and "quality of life (such as difficulty enjoying time with family or friends)," with response options, "extremely likely (>90%)," "very likely (75-90%)," "moderately likely (50-74%)," "somewhat likely (25-49%)," "unlikely (10-24%)," and "very unlikely (<10%)."
The secondary outcome was parent information preferences about possible future limitations. Parents were asked the importance of knowing "how likely it is that cancer or its treatment may affect your child's life in the future" with responses on a 5-point Likert scale. Parents were also asked their preferred level of detail about "the likelihood that your child will have limitations in the future" with responses of "as many details as possible in all situations," "details only in certain situations, such as when the information is important for a decision," or "not to hear a lot of details."
Explanatory factors
Additional items assessed factors we hypothesized could affect parent perception of risk of future limitations including prognosis, communication quality, information quality, emotional impact of information, and trust in physicians. To determine prognostic understanding, parents and physicians were asked the child's likelihood of cure, with response options "extremely likely (>90%)," "very likely (75-90%)," "moderately likely (50-74%)," "somewhat likely (25-49%)," "unlikely (10-24%)," "very unlikely (<10%)," and "no chance of cure." Prognosis estimations were dichotomized as "favorable" (>75% chance of cure) or "less favorable" (<75% chance of cure) given current survival estimates for all children with cancer. Parent and physician estimates of prognosis were considered in agreement if both selected the same estimate of the child's prognosis.
We assessed parent perception of overall medical communication quality utilizing a previously developed scale with items assessing how often the oncologist gives understandable answers to questions, takes adequate time to answer questions, and conveys information in a sensitive manner, with the response options never/sometimes/usually/always. 12 (26) a Parental age was missing for seven; parental gender was missing for three; parental education was unknown for seven, parental race/ethnicity was missing for three; and child gender was unknown for one.
to you to know information about how likely it is that cancer or its treatment may affect your child's life in the future?" Response options included extremely upsetting/very upsetting/somewhat upsetting/a little upsetting/not at all upsetting. Trust in physician was assessed using an item from the Trust in Physician scale. 13, 14 Parent and child attributes were obtained by questionnaire and medical record review. Parents' sex, age, educational level, and race/ethnicity were obtained by questionnaire. Parent dispositional optimism, 15 decisional regret, 16 and decision-making preferences and role 17 were assessed using previously validated scales. Child's diagnosis, date of diagnosis, and date of birth were obtained by medical record review.
Statistical methods
Responses to the items on risk of future limitations and information preferences were summarized descriptively. In the present analysis, risk of future limitations ≥50% in a given category was considered "high risk"; 10-49% chance of future limitations was considered "moderate risk"; and ≤10% chance was deemed "low risk" based on our clinical impression of risk perception. Explanatory variables were categorized consistently with prior analyses of this dataset, unless described otherwise in the methods section.
Statistical analyses were conducted with Stata.
RESULTS
Parent respondents were predominantly female, White, and welleducated (Table 1) . Most parents (87%) thought their child had ≥75% Overall, 92% of parents felt it was extremely or very important to receive information about the likelihood of their child experiencing future effects of cancer treatment, and there were no statistically significant differences in parent information preferences between those whose children were at high, moderate, or low risk of future impairment (Table 4) . Similarly, 86% of parents preferred receiving detailed information about the likelihood of their child experiencing future limitations from cancer or cancer treatment.
DISCUSSION
Most childhood cancer survivors experience long-term health effects of cancer and cancer treatment. In this study, we found that the vast However, fewer than half of parents recognized whether their child's risk of future impairment was high, moderate, or low in three broad domains. Perhaps most strikingly, parents whose children were at the highest risk of future limitations were the least likely to understand this risk.
Discrepant understandings of prognosis or risk of future limitations
between patients or their surrogates and their providers have been previously described in oncology and critical illnesses, with patients or surrogates typically being more optimistic than providers. 10, [18] [19] [20] These discrepant views have been attributed to misunderstandings, differences in beliefs, and lack of explicit discussions about risk, 18, 19 and all of these elements are likely involved in parental misunderstanding of risk of impairment due to cancer and cancer treatment. While our study did not evaluate the reasons for limited parental understanding of risks of future limitations, previous work showed that late effects are discussed far less than acute effects of treatment in initial informed consent discussions. 21 Furthermore, our finding in unadjusted analysis that parents were less likely to understand their child's risk of impairment if they found this information upsetting also suggests that there may be an emotional component that affects how this information is conveyed and perceived. Physicians may adjust the emphasis and content of their early discussions if parents seem upset by the information, and parents who find these discussions distressing may be less able to process the information. Lastly, risk is hard to predict, let alone convey.
Parent understanding of risk of future limitations may be influenced by a variety of factors including prior experiences, optimism, health literacy and numeracy, emotional state, and quality and quantity of information received. Our model accounted for several of these fac-
tors, yet they were not statistically significant predictors of improved understanding in this study. These factors, as well as cultural and linguistic differences in information preferences and understanding, certainly warrant further investigation. While we did not examine the content of initial discussions of information about late effect risks, the discrepancy in understanding highlighted in this study, combined with adults. 29, 30 This study improves our understanding of parents' awareness of 3, 4 and these functional outcomes may be especially germane to parents and families. We used physician-estimated risk of impairment as the comparator, but we know that physicians may also be overly optimistic about a patient's chance of cure or likelihood of future impairment. 6, 10 As the experts on a child's specific treatment risks, and as purveyors of information to parents, physician impression of risk of future impairment was selected to conceptualize broad risk categories and shed some insight into parent-physician communication about long-term outcomes. Finally, this study did not include an evaluation of the initial informed consent discussions between parents and physicians, and therefore we do not know the extent to which late effects risks were discussed or emphasized. However, potential late effects are an important element of informed consent, and studies have shown that late effects are typically mentioned in initial treatment discussions. 21 Strengths of this study include the relatively large sample size and the pairing of parent and physician estimates for the same child. An additional strength is the proximity of survey administration to initial diagnostic and treatment conversations during which risk of late effects are first discussed.
This study shows that parents of children with cancer want detailed information about their children's future risk of functional impairment as a result of cancer and cancer therapy. However, communication practices at diagnosis, combined with challenges processing information during an emotionally overwhelming time, may contribute to a discrepancy between parent and physician estimations of risk of functional limitations. These findings suggest that the early treatment period is a critical yet underutilized moment to begin educating parents and patients about the risks of late effects. But increased focus on potential long-term outcomes in early treatment discussions is not sufficient. Follow-up conversations about risks of late effects should occur throughout therapy and after treatment completion to meet parent information preferences 31 and to ensure appropriate surveillance for late effects. As Oeffinger and Hudson have argued, optimal risk-based survivorship care can and should be a continuum of care "from cancer diagnosis to eventual death regardless of age." 28, 32 Increasing knowledge of risk factors and combinations of factors which predispose to specific late effects can help us identify those at highest risk earlier on in treatment, and these families can be counseled accordingly. 33 Riskbased survivorship care should begin at diagnosis in order to identify those at greatest risk of late effects, integrate consideration of late effects in initial treatment decision making, educate patients and parents using best practices of risk communication, and ensure engagement in optimal survivorship care. 
